Need professional-grade analysis? Visit stockanalysis.com
$12.83B
40.50
547
N/A
Price Chart
Risk-Adjusted Performance
Hunan Jingfeng Pharmaceutical (000908) Price Performance
Hunan Jingfeng Pharmaceutical (000908) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at CNY7.29, up 2.24% from the previous close.
Over the past year, 000908 has traded between a low of CNY4.58 and a high of CNY9.23. The stock has gained 43.5% over this period. It is currently 21.0% below its 52-week high.
Hunan Jingfeng Pharmaceutical has a market capitalization of $12.83B, with a price-to-earnings ratio of 40.50.
About Hunan Jingfeng Pharmaceutical
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the fields of cardiovascular disease, orthopedic pain disease, tumor disease, women and children. The company was founded in 2003 and is headquartered in Shanghai, China.
Compare Hunan Jingfeng Pharmaceutical
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $393.19M
- EBITDA
- $-1,892,604
- Profit Margin
- 39.82%
- EPS (TTM)
- 0.18
- Book Value
- 0.04
Technical Indicators
- 52 Week High
- CN¥9.48
- 52 Week Low
- CN¥4.58
- 50 Day MA
- CN¥6.65
- 200 Day MA
- CN¥6.81
- Beta
- 0.01
Valuation
- Trailing P/E
- 40.50
- Forward P/E
- 33.44
- Price/Sales
- 32.62
- Price/Book
- 336.36
- Enterprise Value
- $12.80B